Chlamydia pneumoniae-immunoglobulin E antibody responses in serum from children with asthma.


Journal

Pathogens and disease
ISSN: 2049-632X
Titre abrégé: Pathog Dis
Pays: United States
ID NLM: 101595366

Informations de publication

Date de publication:
17 01 2023
Historique:
received: 16 05 2023
revised: 19 06 2023
accepted: 03 07 2023
medline: 21 7 2023
pubmed: 5 7 2023
entrez: 5 7 2023
Statut: ppublish

Résumé

Chlamydia pneumoniae is an obligate intracellular bacterium that causes respiratory infections in humans. An association between persistent C. pneumoniae infection and asthma pathogenesis has been described. It is unknown whether specific immunoglobulin E (IgE) is a marker of persistent immune activation responses. Therefore, the association between C. pneumoniae-specific-IgE antibodies (Abs) and interferon (IFN)-gamma produced by C. pneumoniae-stimulated peripheral blood mononuclear cells (PBMC) was examined. Blood was collected and serum separated. PBMC from 63 children with or without stable asthma (N = 45 and 18, respectively) were infected or not infected with C. pneumoniae AR-39 and cultured for up to 7 days. Supernatants were collected, and IFN-gamma levels measured (ELISA). Serum C. pneumoniae-IgE Abs were detected by immunoblotting. C. pneumoniae-IgE Abs were detected in asthmatics (27%), compared with non-asthmatics (11%) (P = NS). IFN-gamma responses were more prevalent among asthmatics who had positive C. pneumoniae-IgE Abs (60%) compared with asthmatics without C. pneumoniae-IgE Abs (20%) (P = 0.1432). IFN-gamma responses in C. pneumoniae-stimulated PBMC from children with asthma were more frequent in children who had specific anti-C. pneumoniae-IgE Abs compared to those who did not. This immune response may reflect persistent infection, which may contribute to ongoing asthma symptoms.

Identifiants

pubmed: 37403376
pii: 7219311
doi: 10.1093/femspd/ftad015
pii:
doi:

Substances chimiques

Immunoglobulin E 37341-29-0
Antibodies, Bacterial 0
Antibodies, Protozoan 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of FEMS.

Auteurs

Tamar A Smith-Norowitz (TA)

State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA.

Anastasiya Shulman (A)

State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA.

Haram Abdelmajid (H)

State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA.

Margaret R Hammerschlag (MR)

State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA.

Rauno Joks (R)

Department of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA.

Diana Weaver (D)

State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA.

Stephan Kohlhoff (S)

State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH